article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

The four governments of the UK established the scheme to increase the climate ambition of the UK’s carbon pricing policy, whilst also protecting the competitiveness of UK businesses. Large energy users such as pharmaceutical manufacturers can play an important role in protecting grid stability while enabling more renewable generation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Who’s saying what? Corporate governance mentions in company filings of pharmaceutical industry increased by 141% in Q1 2023

Pharmaceutical Technology

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

article thumbnail

Who’s saying what? Corporate governance mentions in company filings of pharmaceutical industry increased by 141% in Q1 2023

Pharmaceutical Technology

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

article thumbnail

Non-stop investment from CMOs and US Government into continuous manufacturing

Pharmaceutical Technology

The US House of Representatives separately passed a bill on continuous manufacturing on 19 October last year. The 'National Centres of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021' (H.R.

article thumbnail

Who’s saying what? Environmental sustainability mentions in company filings of pharmaceutical industry increased by 114% in Q1 2023

Pharmaceutical Technology

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Starting at 100 in 2020, an index over 100 is more positive. The overall index for environmental sustainability in Q1 2023 was 107.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. Such studies can also help companies prepare for their upcoming inspections by enabling them to identify and rectify any issues.

FDA 94